Ana Giménez‐Capitán

3.1k total citations
77 papers, 1.9k citations indexed

About

Ana Giménez‐Capitán is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ana Giménez‐Capitán has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 43 papers in Pulmonary and Respiratory Medicine and 39 papers in Oncology. Recurrent topics in Ana Giménez‐Capitán's work include Lung Cancer Treatments and Mutations (38 papers), Cancer Genomics and Diagnostics (21 papers) and Lung Cancer Research Studies (13 papers). Ana Giménez‐Capitán is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Cancer Genomics and Diagnostics (21 papers) and Lung Cancer Research Studies (13 papers). Ana Giménez‐Capitán collaborates with scholars based in Spain, United States and Japan. Ana Giménez‐Capitán's co-authors include Rafael Rosell, Niki Karachaliou, Miguel Ángel Molina‐Vila, Carlota Costa, Santiago Viteri, Cristina Teixidó, Ana Drozdowskyj, Jordi Bertrán-Alamillo, Clara Mayo and Miquel Tarón and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ana Giménez‐Capitán

70 papers receiving 1.9k citations

Peers

Ana Giménez‐Capitán
Kazuhiko Shien Japan
Christopher J. Lafargue United States
Luigi Formisano Italy
Soji Kakiuchi Japan
Lynne D. Berry United States
Wassim Abida United States
Antonio Marchetti Italy
Carlota Costa Spain
Raushan T. Kurmasheva United States
Belén Rubio‐Viqueira Spain
Kazuhiko Shien Japan
Ana Giménez‐Capitán
Citations per year, relative to Ana Giménez‐Capitán Ana Giménez‐Capitán (= 1×) peers Kazuhiko Shien

Countries citing papers authored by Ana Giménez‐Capitán

Since Specialization
Citations

This map shows the geographic impact of Ana Giménez‐Capitán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Giménez‐Capitán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Giménez‐Capitán more than expected).

Fields of papers citing papers by Ana Giménez‐Capitán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Giménez‐Capitán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Giménez‐Capitán. The network helps show where Ana Giménez‐Capitán may publish in the future.

Co-authorship network of co-authors of Ana Giménez‐Capitán

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Giménez‐Capitán. A scholar is included among the top collaborators of Ana Giménez‐Capitán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Giménez‐Capitán. Ana Giménez‐Capitán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alonso, Ana, Ana Giménez‐Capitán, Laura López, et al.. (2024). Older Patients With Interstitial Lung Disease Feature a Distinct Clinical Profile. SHILAP Revista de lepidopterología. 6(4). 100374–100374. 1 indexed citations
2.
Bertrán-Alamillo, Jordi, Núria Jordana‐Ariza, Ana Giménez‐Capitán, et al.. (2024). Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways. Translational Oncology. 40. 101878–101878.
3.
D’Ambrosi, Silvia, Stavros Giannoukakos, Jillian Wilhelmina Paulina Bracht, et al.. (2023). Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection. International Journal of Molecular Sciences. 24(5). 4881–4881. 13 indexed citations
4.
Rosell, R., Jordi Codony‐Servat, Jessica González, et al.. (2023). KRAS G12C-mutant driven non-small cell lung cancer (NSCLC). Critical Reviews in Oncology/Hematology. 195. 104228–104228. 14 indexed citations
5.
6.
Ito, Masaoki, et al.. (2023). Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC. JTO Clinical and Research Reports. 4(12). 100604–100604. 3 indexed citations
7.
Rosell, Rafael, Mariacarmela Santarpía, Andrés Aguilar, et al.. (2023). Liquid biopsy in detecting early non-small cell lung cancer. SHILAP Revista de lepidopterología. 1. 100001–100001. 1 indexed citations
8.
Giannoukakos, Stavros, et al.. (2022). Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies. Biomarker Research. 10(1). 57–57. 24 indexed citations
9.
Ito, Masaoki, Yasuhiro Tsutani, Ana Giménez‐Capitán, et al.. (2021). Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung. Journal of Cancer Research and Clinical Oncology. 147(12). 3709–3718. 11 indexed citations
10.
Attili, Ilaria, Laura Bonanno, Niki Karachaliou, et al.. (2020). SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer. Translational Lung Cancer Research. 9(5). 1810–1821. 11 indexed citations
11.
Karachaliou, Niki, Óscar Arrieta, Ana Giménez‐Capitán, et al.. (2020). BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib. JTO Clinical and Research Reports. 2(3). 100113–100113. 9 indexed citations
12.
Bertrán-Alamillo, Jordi, Valérie Cattan, Marie Schoumacher, et al.. (2019). AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. Nature Communications. 10(1). 1812–1812. 88 indexed citations
13.
Codony‐Servat, Jordi, Miguel Ángel Molina‐Vila, Jordi Bertrán-Alamillo, et al.. (2018). Anti–Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells. Journal of Thoracic Oncology. 13(9). 1324–1337. 29 indexed citations
14.
Karachaliou, Niki, Jillian Wilhelmina Paulina Bracht, Ana Drozdowskyj, et al.. (2018). Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(2). 304–310. 13 indexed citations
15.
Jacobsen, Kirstine, Jordi Bertrán-Alamillo, Miguel Ángel Molina‐Vila, et al.. (2017). Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer. Nature Communications. 8(1). 410–410. 118 indexed citations
16.
Costa, Carlota, Miguel Angel Molina, Ana Drozdowskyj, et al.. (2014). The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial. Clinical Cancer Research. 20(7). 2001–2010. 180 indexed citations
17.
Benlloch, Susana, María Luisa Botero, Clara Mayo, et al.. (2014). Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial. PLoS ONE. 9(2). e89518–e89518. 34 indexed citations
18.
Karachaliou, Niki, Carlota Costa, Ana Giménez‐Capitán, et al.. (2013). BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations. Journal of Thoracic Oncology. 8(3). 295–300. 15 indexed citations
19.
Bover, Isabel, Christian Rolfo, Eloísa Jantus‐Lewintre, et al.. (2011). Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop. Lung Cancer. 74(3). 535–543.
20.
Santarpía, Mariacarmela, María Sanchez-Ronco, Carlota Costa, et al.. (2011). mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients. Journal of Translational Medicine. 9(1). 163–163. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiko Shien Breakdown of academic impact, for papers by Christopher J. Lafargue Breakdown of academic impact, for papers by Luigi Formisano Breakdown of academic impact, for papers by Soji Kakiuchi Breakdown of academic impact, for papers by Lynne D. Berry Breakdown of academic impact, for papers by Wassim Abida Breakdown of academic impact, for papers by Antonio Marchetti Breakdown of academic impact, for papers by Carlota Costa Breakdown of academic impact, for papers by Raushan T. Kurmasheva Breakdown of academic impact, for papers by Belén Rubio‐Viqueira
Rankless by CCL
2026